Stuart Kurlander, a healthcare and life sciences partner in Latham & Watkins’ Washington, D.C. office, is Global Co-Chair of the Israel Practice and former Global Co-Chair of the Healthcare & Life Sciences Practice. Mr. Kurlander has more than 25 years of experience providing healthcare regulatory, reimbursement, fraud and abuse, corporate, and litigation counsel to healthcare and life science companies including medical device and diagnostic manufacturers, pharmaceutical and biotech firms, healthcare providers, digital health businesses, and other sectors of the industry.
Mr. Kurlander represents healthcare interests at all levels of government involving in matters before the Centers for Medicare and Medicaid Services (CMS), Office of the Inspector General (OIG), and the Public Health Service (PHS). He serves as outside regulatory counsel to several private equity funds, investment banks, and venture capital funds where he routinely advises on transactions. Additionally, Mr. Kurlander:
- Counsels companies on Medicare and Medicaid coverage, coding, and reimbursement matters
- Advises companies on federal and state fraud and abuse matters including development of compliance programs
- Represents healthcare and life science companies on regulatory issues related to mergers and acquisitions, IPOs, financings, and joint ventures in the US and also advises on transactions in the Middle East, Europe, and Asia
- Provides healthcare and life sciences counsel in complex litigation matters, including qui tam (whistleblowers lawsuits), and regularly negotiates with the US Department of Justice (DOJ), the US Department of Health and Human Services Office (HHS) of Inspector General, and the Center for Medicare and Medicaid Services (CMS)
Mr. Kurlander previously served as an attorney in the General Counsel’s office of the US HHS, CMS where he drafted Medicare and Medicaid regulations, and litigated complex Medicare and Medicaid cases in federal court.
Mr. Kurlander has been recognized for several years as a leading healthcare and life sciences lawyer by Chambers USA and The Legal 500 US and as an MVP by Law360. He was named a regulatory Life Sciences Star by LMG Euromoney and as one of the Top 10 outstanding hospital and nursing home lawyers by Nightingale’s Healthcare News. He has also been recognized in the Legally Israel 100 by IsraelDesks which recognizes practitioners “who take a proactive, instrumental and hands-on role with respect to Israel.”
Additionally, he regularly authors legal and regulatory articles and columns in major healthcare publications, speaks nationally on emerging topics and trends, and is active in national and international healthcare, legal, civic, and community organizations.